GN
GNOG.LSE Global X Genomics & Biotechnology UCITS ETF USD Acc GBP
- GBP
No recent price
- Total assets
- 8.06M
- Expense ratio
- 0.49%
- Dividend yield
- -
- 1-year return
- +49.53%
- Holdings
- 50
- Since
- 2021
Fund data as reported by the issuer, updated Nov 3, 2026. Total assets are in the fund's base currency.
What does GNOG.LSE invest in?
Tracks Morningstar Gbl Biotechnology NR USD- Mostly US stocks (92.9%)
- Largest sector: Healthcare (95.1%)
- Largest region: North America (98.6%)
- Top 3 holdings: 24.2% of the fund
Asset allocation
- US stocks 92.9%
- Non-US stocks 5.0%
- Cash 0.2%
Top holdings
- Moderna Inc 10.42%
- Twist Bioscience Corp 7.13%
- 10X Genomics Inc 6.64%
- Illumina Inc 6.07%
- Natera Inc 5.50%
Global X Genomics & Biotechnology UCITS ETF USD Acc GBP performance
Sharpe ratio 0.76- This year
- +48.28%
- 1 year
- +49.53%
- 3 years
- +22.76%
- 5 years
- 0.00%
Volatility 27.4% over 1 year and 30.2% over 3 years. High: expect large swings.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
GNOG.LSE price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
Global X Genomics & Biotechnology UCITS ETF USD Acc GBP top holdings
54.7% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Moderna Inc MRNA.US | Healthcare | United States | 10.42% |
| Twist Bioscience Corp TWST.US | Healthcare | United States | 7.13% |
| 10X Genomics Inc TXG.US | Healthcare | United States | 6.64% |
| Illumina Inc ILMN.US | Healthcare | United States | 6.07% |
| Natera Inc NTRA.US | Healthcare | United States | 5.50% |
| Guardant Health Inc GH.US | Healthcare | United States | 5.37% |
| Genscript Biotech Corp 1548.HK | Healthcare | Hong Kong | 3.59% |
| Vertex Pharmaceuticals Inc VRTX.US | Healthcare | United States | 3.42% |
| Qiagen NV QGEN.US | Healthcare | United States | 3.28% |
| Bio-Techne Corp TECH.US | Healthcare | United States | 3.27% |
The 10 largest of 50 holdings.
GNOG.LSE sector exposure
- Healthcare95.1%
- Technology0.3%
Share of the stocks in the fund.
GNOG.LSE regional exposure
- North America98.6%
- Europe Developed3.6%
- United Kingdom1.3%
Share of the stocks in the fund.
Company size
Average market cap 16.0B- Mega cap3.5%
- Big cap7.2%
- Medium cap28.7%
- Small cap37.0%
- Micro cap18.4%
Global X Genomics & Biotechnology UCITS ETF USD Acc GBP fund profile
- Fund name
- Global X Genomics & Biotechnology UCITS ETF USD Acc GBP
- Ticker
- GNOG.LSE
- Exchange
- London Exchange
- Issuer
- Global X
- Index tracked
- Morningstar Gbl Biotechnology NR USD
- Category
- Healthcare Equity
- Domicile
- Ireland
- Inception date
- Nov 2, 2021
- Trading currency
- GBP
- Expense ratio
- 0.49%